Cargando…
Validation of Clinical Risk Models for Clostridioides difficile-Attributable Outcomes
Clostridioides difficile is the leading health care-associated pathogen, leading to substantial morbidity and mortality; however, there is no widely accepted model to predict C. difficile infection severity. Most currently available models perform poorly or were calibrated to predict outcomes that a...
Autores principales: | Madden, Gregory R., Petri, William A., Costa, Deiziane V. S., Warren, Cirle A., Ma, Jennie Z., Sifri, Costi D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295569/ https://www.ncbi.nlm.nih.gov/pubmed/35727061 http://dx.doi.org/10.1128/aac.00676-22 |
Ejemplares similares
-
In Vitro Activity of Omadacycline, a New Tetracycline Analog, and Comparators against Clostridioides difficile
por: Begum, Khurshida, et al.
Publicado: (2020) -
Epidemiology of Clostridioides difficile infections, France, 2010 to 2017
por: Colomb-Cotinat, Mélanie, et al.
Publicado: (2019) -
Sentinel surveillance and epidemiology of Clostridioides difficile in Denmark, 2016 to 2019
por: Persson, Søren, et al.
Publicado: (2022) -
709. Post-Clostridioides difficile Infection Neuroinflammatory Response in an Animal Model
por: Yang, Suemin E, et al.
Publicado: (2023) -
Propensity-Matched Cost of Clostridioides difficile Infection Overdiagnosis
por: Madden, Gregory R, et al.
Publicado: (2020)